Skye Bioscience, Inc.
No trades
No trades
Peers for comparison
Key facts today
On November 10, a jury returned a unanimous verdict in favor of Skye Bioscience, Inc. (SKYE) in the Wendy Cunning lawsuit, according to an SEC filing. 1
−10.18 USD
−55.92 M USD
0.00 USD
2.98 M
Next report date
Report period
EPS estimate
Revenue estimate
Company info
Sector
Industry
CEO
Punit S. Dhillon
Website
Headquarters
San Diego
Founded
2011
ISIN
US83086J3095
CUSIP
83086J309
FIGI
BBG00433GZN1
Identifiers
ISIN US83086J3095
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the business of research and development activities related to developing medicine for obesity and metabolic diseases. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
Skye Bioscience ($SKYE) - A Strong BuySkye Bioscience (NASDAQ: SKYE) is gaining attention due to its lead obesity candidate, nimacimab, currently in Phase 2 trials with results expected in Q3/Q4 2025. Improved earnings and potential short-squeeze setup make this a high-reward opportunity.
Why NASDAQ:SKYE is a Buy:
Bullish Divergence
SKYE Long Trade Setup (30-Min Chart) !### 🚀 **📈🔥**
🔍 **Stock:** SKYE (NASDAQ)
⏳ **Timeframe:** 30-Min Chart
📈 **Setup Type:** Bullish Reversal
### 📍 **Trade Plan:**
✅ **Entry Zone:** **$3.15 - $3.22** (Falling Wedge Support + Breakout Potential)
🚀 **Take Profit 1 (TP1):** **$3.67** (Key Resistance)
🚀 **Take Profit 2 (TP2)
SKYE Long Trade Setup (30-Min Chart)!🚀 📈🔥
🔍 Stock: SKYE (NASDAQ)
⏳ Timeframe: 30-Min Chart
📈 Setup Type: Bullish Breakout
📍 Trade Plan:
✅ Entry: $3.75 (Breakout Confirmation)
❌ Stop-Loss (SL): $3.54 (Below key support for risk management)
🎯 Target 1: $3.98 (First Resistance Level)
🚀 Target 2: $4.25 (Major Resistance Level – Moon Shot
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
Today, SKYE trades at 1.11 USD.
For broader market analysis, dive into the technicals on the Skye Bioscience, Inc. stock price chart and read the latest SKYE news:
– Skye Bioscience - Jury Returns Unanimous Verdict In Favor Of Co On Nov 10, In Wendy Cunning Lawsuit - SEC Filing
– Skye Bioscience Wins Unanimous Jury Verdict in Former Employee Lawsuit
– SKYE Q3'26 Earnings: EPS estimate is (1.14) USD
For broader market analysis, dive into the technicals on the Skye Bioscience, Inc. stock price chart and read the latest SKYE news:
– Skye Bioscience - Jury Returns Unanimous Verdict In Favor Of Co On Nov 10, In Wendy Cunning Lawsuit - SEC Filing
– Skye Bioscience Wins Unanimous Jury Verdict in Former Employee Lawsuit
– SKYE Q3'26 Earnings: EPS estimate is (1.14) USD
Markets don't sleep, here's what's going on with SKYE at the moment:
– Skye Bioscience - Jury Returns Unanimous Verdict In Favor Of Co On Nov 10, In Wendy Cunning Lawsuit - SEC Filing
– Skye Bioscience Wins Unanimous Jury Verdict in Former Employee Lawsuit
– SKYE Q3'26 Earnings: EPS estimate is (1.14) USD
See more updates in real-time with our News Flow.
– Skye Bioscience - Jury Returns Unanimous Verdict In Favor Of Co On Nov 10, In Wendy Cunning Lawsuit - SEC Filing
– Skye Bioscience Wins Unanimous Jury Verdict in Former Employee Lawsuit
– SKYE Q3'26 Earnings: EPS estimate is (1.14) USD
See more updates in real-time with our News Flow.
Skye Bioscience, Inc. is scheduled to release its next earnings report on Nov 13, 2026.
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
SKYE stock is 14.00% volatile and has beta coefficient of 2.82.
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like SKYE are typically less volatile than smaller companies
Track every detail on Skye Bioscience, Inc. stock chart and check out the list of the most volatile stocks — is Skye Bioscience, Inc. there?
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like SKYE are typically less volatile than smaller companies
Track every detail on Skye Bioscience, Inc. stock chart and check out the list of the most volatile stocks — is Skye Bioscience, Inc. there?
To understand the SKYE stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — +17.52%
– 1 week — −4.42%
– 1 month — −34.55%
SKYE all-time low was 0.50 USD (Nov 9, 2026), and its highest price is 22,000.00 USD (Dec 12, 2014). Find more dynamics in the Stock Heatmap and on the Skye Bioscience, Inc. stock chart.
– 1 day — +17.52%
– 1 week — −4.42%
– 1 month — −34.55%
SKYE all-time low was 0.50 USD (Nov 9, 2026), and its highest price is 22,000.00 USD (Dec 12, 2014). Find more dynamics in the Stock Heatmap and on the Skye Bioscience, Inc. stock chart.
Skye Bioscience, Inc. market capitalization is 4.78 M, representing the total value of all its outstanding shares (price × shares outstanding).
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Skye Bioscience, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Skye Bioscience, Inc. stacks up against other companies
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Skye Bioscience, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Skye Bioscience, Inc. stacks up against other companies
The safest way to buy Skye Bioscience, Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.
You can trade SKYE directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
You can trade SKYE directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 13, 2026, the company has 12 employees.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Investing in Skye Bioscience, Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.
First, study Skye Bioscience, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our SKYE technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell
Combine fundamental and technical analysis for better results.
First, study Skye Bioscience, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our SKYE technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell
Combine fundamental and technical analysis for better results.
Skye Bioscience, Inc. stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, Skye Bioscience, Inc. stocks trade under the symbol SKYE.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
SKYE earnings for the last quarter are −2.16 USD per share, whereas the estimation was −1.91 USD, resulting in a −13.30% surprise. The estimated earnings for the next quarter are −1.14 USD per share.
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in Skye Bioscience, Inc. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in Skye Bioscience, Inc. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
Skye Bioscience, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
What it might mean:
– Stable demand: Sales are holding steady without clear growth or decline
– Mature business phase: Growth may be slowing in core segments
– Offsetting factors: Strength in some areas may be balancing weakness in others
What to look at next in Skye Bioscience, Inc. financials:
– Margins: Profitability may improve or decline even if revenue is flat
– Net income & EPS: Cost control or share buybacks can still drive earnings changes
– Segment breakdown: Some business lines may be growing while others shrink
What it might mean:
– Stable demand: Sales are holding steady without clear growth or decline
– Mature business phase: Growth may be slowing in core segments
– Offsetting factors: Strength in some areas may be balancing weakness in others
What to look at next in Skye Bioscience, Inc. financials:
– Margins: Profitability may improve or decline even if revenue is flat
– Net income & EPS: Cost control or share buybacks can still drive earnings changes
– Segment breakdown: Some business lines may be growing while others shrink
Yes, you can track Skye Bioscience, Inc. financials in yearly and quarterly reports right on TradingView.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
SKYE net income for the last quarter is −10.79 M USD, while the quarter before that showed −12.51 M USD of net income which accounts for 13.77% change.
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in Skye Bioscience, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in Skye Bioscience, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Skye Bioscience, Inc. does not currently pay dividends to its shareholders.
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
SKYE reached its all-time high of 22,000.00 USD on Dec 12, 2014. Its all-time low was 0.50 USD and was reached on Nov 9, 2026.
Explore the Skye Bioscience, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Explore the Skye Bioscience, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Analyst forecasts suggest a price range between 16.00 USD and 16.00 USD for SKYE, based on current estimates.
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance




